Sanofi is to buy Principia Biopharma for up to $3.68 billion ... give it full control of the brain-penetrant BTK inhibitor, SAR442168, making marketing more efficient and eliminating any royalty ...
Liver injuries also prompted the FDA to impose a partial clinical hold on Sanofi's BTK inhibitor tolebrutinib (SAR442168 ... of its $3.7 billion buyout of Principia Biopharma.
COLUMBIA, Mo – The Principia Boys Basketball team made history in Columbia on Thursday. Principia beat KIPP KC 76-56 in the Class 3 state championship, marking the first ever title in program ...
Refers to the latest 2 years of stltoday.com stories. Cancel anytime. Principia's Paige Ivy (33) moves the ball around South Shelby's Charlie Roush (34) during a Class 3 state girls basketball ...
Both teams were dominant in their semifinal wins on Wednesday night. Principia beat Portageville 61-29, followed by Fair Grove's 55-22 victory over Lone Jack. Both were ranked as the top two teams ...
Get up-to-the-minute news sent straight to your device.
Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) (HERCULES). ClinicalTrials.gov. Updated February 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results